Serum paraoxonase type-1 activity in pigs: Assay validation and evolution after an induced experimental inflammation

Veterinary Immunology and Immunopathology

Volumn 163, Issue 3-4, 2015, Pages 210-215

  Escribano, Damián ^a   Tvarijonaviciute, Asta ^a   Tecles, Fernando ^a   Cerón, José J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Acute phase protein; Assay validation; Inflammation; Paraoxonase type 1; Serum pigs

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; ARYLDIALKYLPHOSPHATASE 1; BUTYROLACTONE; C REACTIVE PROTEIN; PHENYLACETIC ACID; TURPENTINE; TURPENTINE OIL; ARYLDIALKYLPHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; EXPERIMENTAL INFLAMMATION; HYDROLYSIS; LIMIT OF DETECTION; MALE; NONHUMAN; PORCINE MODEL; SPECTROPHOTOMETRY; VALIDATION PROCESS; ANIMAL; BLOOD; CHEMICALLY INDUCED; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; PHYSIOLOGY; PIG; PROCEDURES; REPRODUCIBILITY; SPECTROSCOPY; SWINE DISEASE; VALIDATION STUDY;

SUIDAE; SUS;

ANIMALS; ARYLDIALKYLPHOSPHATASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION; REPRODUCIBILITY OF RESULTS; SPECTRUM ANALYSIS; SWINE; SWINE DISEASES; TURPENTINE;

EID: 84922248498     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2014.12.002     Document Type: Article

References (28)

1. Camps J., Marsillach J., Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit. Rev. Clin. Lab. Sci. 2009, 46:83-106.
2. Ceron J.J., Tecles F., Tvarijonaviciute A. Serum paraoxonase 1 (PON1) measurement: an update. BMC Vet. Res. 2014, 10:74.
3. Chun C.K., Ozer E.A., Welsh M.J., Zabner J., Greenberg E.P. Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3587-3590.
4. Dantoine T., Debord J., Charmes J.P., Merle L., Marquet P., Lachatre G., Leroux-Robert C. Decrease of serum paraoxonase activity in chronic renal failure. J. Am. Soc. Nephrol. 1998, 9:2082-2088.
5. De Keyzer D., Karabina S.A., Wei W., Geeraert B., Stengel D., Marsillach J., Camps J., Holvoet P., Ninio E. Increased PAFAH and oxidized lipids are associated with inflammation and atherosclerosis in hypercholesterolemic pigs. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2041-2046.
6. Farid A.S., Honkawa K., Fath E.M., Nonaka N., Horii Y. Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows. BMC Vet. Res. 2013, 11:9-73.
7. Gutiérrez A.M., Martínez-Subiela S., Eckersall P.D., Cerón J.J. C-reactive protein quantification in porcine saliva: a minimally invasive test for pig health monitoring. Vet. J. 2009, 181:261-265.
8. Heegaard P.M., Stockmarr A., Piñeiro M., Carpintero R., Lampreave F., Campbell F.M., Eckersall P.D., Toussaint M.J., Gruys E., Sorensen N.S. Optimal combinations of acute phase proteins for detecting infectious disease in pigs. Vet. Res. 2011, 17:42-50.
9. Huen K., Richter R., Furlong C., Eskenazi B., Holland N. Validation of PON1 enzyme activity assays for longitudinal studies. Clin. Chim. Acta 2009, 402:67-74.
10. James R.W., Deakin S.P. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radic. Biol. Med. 2004, 37:1986-1994.
11. Khersonsky O., Tawfik D.S. Chromogenic and fluorogenic assays for the lactonase activity of serum paraoxonases. ChemBioChem 2006, 7:49-53.
12. Kjelgaard-Hansen M., Martínez-Subiela S., Petersen H.H., Jensen A.L., Ceron J.J. Evaluation and comparison of two immunoturbidimetric assays for the heterologous determination of porcine serum C-reactive protein. Vet. J. 2007, 173:571-577.
13. Liao F., Zhu X., Wang Y., Zhao Y., Zhu L., Zuo Y. Correlation of serum arylesterase activity on phenylacetate estimated by the integrated method to common classical biochemical indexes of liver damage. J. Zheijang Univ. Sci. B 2007, 8:237-241.
14. Marsillach J., Aragonès G., Beltrán R., Caballeria J., Pedro-Botet J., Morcillo-Suárez C., Navarro A., Joven J., Camps J. The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. Clin. Biochem. 2009, 42:91-98.
15. Martinez-Subiela S., Eckersall P.D., Campbell F.M., Parra M.D., Fuentes P., Ceron J.J. A time-resolved immunofluorometric assay for porcine C-reactive protein quantification in whole blood. Luminescence 2007, 22:171-176.
16. Miyamoto T., Takahashi Y., Oohashi T., Sato K., Oikawa S. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins. J. Vet. Med. Sci. 2005, 67:243-248.
17. Nafikov R.A., Beitz D.C. Carbohydrate and lipid metabolism in farm animals. J. Nutr. 2007, 137:702-705.
18. Novak F., Vavrova L., Kodydkova J., Novak F., Hynkova M., Zak A., Novakova O. Decreased paraoxonase activity in critically ill patients with sepsis. Clin. Exp. Med. 2010, 10:21-25.
19. Richter R.J., Jarvic G.P., Furlong C.E. Paraoxonase 1 (PON1) status and substrate hydrolysis. Toxicol. Appl. Pharmacol. 2009, 235:1-9.
20. Sarkar M., Harsch C.K., Matic G.T., Hoffman K., Norris J.R., Otto T.C., Lenz D.E., Cerasoli D.M., Magliery T.J. Solubilization and humanization of paraoxonase-1. J. Lipids 2012, 2012:610937.
21. Tecles F., Fuentes P., Martínez Subiela S., Parra M.D., Muñoz A., Cerón J.J. Analytical validation of commercially available methods for acute phase proteins quantification in pigs. Res. Vet. Sci. 2007, 83:133-139.
22. Turk R., Habuš J., Flegar-Meštrić Z., Svetina A., Mojčec V., Perkov S., Belić M., Starešina V., Turk N. Serum platelet-activating factor acetylhydrolase and paraoxonase-1 activity in horses infected with Leptospira spp. Acta Trop. 2011, 118:97-100.
23. Turk R., Juretić D., Geres D., Svetina A., Turk N., Flegar-Mestrić Z. Influence of oxidative stress and metabolic adaptation on PON1 activity and MDA level in transition dairy cows. Anim. Reprod. Sci. 2008, 108:98-106.
24. Tvarijonaviciute A., Ceron J.J., Holden S.L., Morris P.J., Biourge V., German A.J. Effects of weight loss in obese cats on biochemical analytes related to inflammation and glucose homeostasis. Domest. Anim. Endocrinol. 2012, 42:129-141.
25. Tvarijonaviciute A., Kocaturk M., Cansev M., Tecles F., Ceron J.J., Yilmaz Z. Serum butyrylcholinesterase and paraoxonase 1 in a canine model of endotoxemia: effects of choline administration. Res. Vet. Sci. 2012, 93:668-674.
26. Tvarijonaviciute A., Tecles F., Caldin M., Tasca S. Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs. Am. J. Vet. Res. 2012, 73:34-41.
27. van Himbergen T.M., Roest M., Graaf J., Jansen E.H., Hattori H., Kastelein J.J., Voorbij H.A., Stalenhoef A.F., van Tits L.J. Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia. J. Lipid Res. 2005, 46:445-451.
28. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 1995, 96:2882-2891.